⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Stemline Therapeutics just got measured.
4/10 means Stemline Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Management Business Development Product Pipeline Scientific Presentations Clinical Trials Expanded Access News & Media Contact Us Reporting Concerns BPDCN x Stemline Therapeutics is part of Menarini Group About ELZONRIS® ELZONRIS (tagraxofusp-erzs) is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older.
Category: Healthcare
stemline.com2
Structured Data
3
Content Structure
5
Entity Clarity
4
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Stemline Therapeutics.
Scored by Engagemii on June 10, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/stemline
Cite this score: Engagemii (2026). "AEO Score for Stemline Therapeutics." Retrieved from https://engagemii.com/aeo/brands/stemline
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform